Sputnik V
Vaccine
THE 1st REGISTERED COVID-19 VACCINE
PROVEN HUMAN ADENOVIRAL SECTOR THECHNOLOGY
KEY FACTS

The first registered COVID-19 vaccine in the world

Prime-boost vaccination achieves recognized

long lasting immune response

Safe and well-studied platform since 1953 and used for the vaccination of over 10 min people

Over 44,000 people in Sputnik V clinical trials worldwide

Countries with over 50% of world population have expressed interest in Sputnik V vaccination

Over 1bn people to be vaccinated by Sputnik V in 2020-2022
(*) Vector platform based on human adenoviruses
Mexico
Venezuela
Brazil
Peru
Argentina
Bolivia
UAE
Saudi Arabia
Israel
Egypt
Algeria
Russia
Belarus
Kazakhstan
Uzbekistan
Iran
Kuwait
Turkey
Serbia
Bosnia and Herzegovina
Palestine
Hungary
Recognition from the Global Scientific Community
Sputnik V Vaccine official website
South Korea
China
Nepal
Vietnam
Philippines
Indonesia
Malaysia
Bangladesh
India
Paraguay
SPUTNIK V - A VACCINE FOR ALL HUMANKIND
Sputnik V’s efficacy and safety results are validated by internationally peer reviewed data published in The Lancet
Efficacy
confirmed at
91.6%
Protection against
severe cases
100%
FACING COVID-19
You are not logged in